# 此超級綜合評等是基於以下評等的加權平均結果。

*biotech · news · 2026-06-01 · MarketScreener*

## Key points

- Trader 超級評等以估值、4 個月盈餘修正及能見度加權。
- Investor 超級綜合評等包含基本面、估值、1 年盈餘修正及能見度。
- Global 綜合評等平均基本面、估值、財務預估修正、共識及能見度。
- Quality 綜合評等平均報酬率、獲利能力、財務報告品質及財務健康。

Trader This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Investor This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions. Global This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions. Quality This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.

[Read the full story on MarketScreener](https://www.marketscreener.com/news/fulcrum-scraps-sickle-cell-drug-program-after-fda-raises-cancer-risk-concerns-ce7f5dd9dc8af122)

---

Canonical: https://newsio.io/zh-TW/n/32b1e023-3927-48ba-8772-71bf9308e5af/
Summarized by Newsio from MarketScreener. https://newsio.io/how-it-works